Sector ratings Roche Holding AG

Equities

Market Closed - Swiss Exchange Other stock markets 16:30:00 19/01/2026 GMT			5-day change	1st Jan Change
346.80 ^CHF	-0.60%		+1.26%	+5.67%

01-18	Bayer Receives EU Approval for High-Dose Eylea in Another Indication	DP
01-16	Goldman Sachs Upgrades Roche to Neutral, Boosts PT	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
ROCHE HOLDING AG	371B		AA
ELI LILLY AND COMPANY	930B		A
JOHNSON & JOHNSON	527B		BBB
ABBVIE INC.	379B		AA
ASTRAZENECA PLC	292B		A
NOVARTIS AG	276B		AAA
MERCK & CO., INC.	270B		A
NOVO NORDISK A/S	268B		A
AMGEN INC.	178B		A
GILEAD SCIENCES, INC.	155B		AAA
PFIZER INC.	146B		BBB
SANOFI	113B		A
BRISTOL-MYERS SQUIBB COMPANY	112B		A
VERTEX PHARMACEUTICALS INCORPORATED	112B		AA
GSK PLC	97.55B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	85.93B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	59.15B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	50.71B		AA
ALNYLAM PHARMACEUTICALS, INC.	47.46B		AA	-
Average	226.7B		AA
Weighted average by Cap.			AA